Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

NCT05628376 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT05628376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05628376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
Lead sponsor
University College, London
Phase
Observational
Overall status
Recruiting
Start date
October 20, 2023
Completion date
June 30, 2034
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, non-small cell, pleural mesothelioma, small cell lung cancer